A clinical trial showed CAR-T cell therapy may shrink aggressive brain and spinal cord tumours in young patients.

Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...

KNOXVILLE, Tenn. (WATE) — Chris Patterson was a Knoxville fire captain when he rescued a woman from a house fire in December ...

"The technology's responsiveness to individual pain levels and real-time adaptation to patient needs ... Nevro's ...

Spinal cord injury care has yet to receive the focused attention it deserves from the government In the realm of spinal cord ...

The company announced receiving CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system ... such as ...

Scientists developed a genetic tool that can quickly identify nearly any type of pathogenic infection, including those caused ...

The company is facing significant headwinds in its U.S. core Spinal Cord Stimulation (SCS) market, where sales have continued to decline and trials have decelerated, raising concerns about the company ...

Kessler Foundation researchers published new findings on neuromodulation in individuals with high-level spinal cord injury (SCI) using spinal cord transcutaneous stimulation (scTS). This promising ...

The global spinal fusion market is on track for substantial expansion, with recent projections highlighting a significant surge in its valuation. According to the latest market analysis, the spinal ...